Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Shifting Trends in the Indication of Glucagon-like Peptide-1 Receptor Agonist Prescriptions: A Nationwide Analysis

Yeo, Yee Hui, Rezaie, Ali, Hsieh, Tina Yi-Jin, Hu, Xiaoqin, Gaddam, Srinivas, Ma, Kevin Sheng-Kai, Gastrointestinal Motility and Metabolic Pharmacoepidemiology Group, Mohamed, Ghada, Lee, Gin Yi, Huang, Pin-Chia, Watson, Rabindra, Mohamed, Ghada, Lee, Gin Yi, Huang, Pin-Chia, Watson, Rabindra·2024·Annals of Internal Medicine

Abstract

in the TriNetX database. The GLP-1RAs include exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, and semaglutide. Obesity-related comorbid conditions include asthma, metabolic syndrome, gastroesophageal re fl ux disease, metabolic dysfunction – associated steatotic liver disease/steatohepatitis, obstructive sleep apnea, and osteoarthritis. New users were de fi ned as persons who received the fi rst GLP-1RA prescription during the study year/period. The age and sex standardization was conducted using the direct method, with the 2020 U.S. Census as the stand-ardpopulation.

Overview

Integrity signals

Registry

Crossref · 10.7326/m24-0019

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 3 references

Cited by

See all 90

Metadata

Authors
Yeo, Y. H., Rezaie, A., Hsieh, T. Y.-J., Hu, X., Gaddam, S., Ma, K. S.-K., Gastrointestinal Motility and Metabolic Pharmacoepidemiology Group, Mohamed, G., Lee, G. Y., Huang, P.-C., Watson, R., Mohamed, G., Lee, G. Y., Huang, P.-C., & Watson, R.
Affiliations
  • Cedars-Sinai Medical Center (US)
  • Beth Israel Deaconess Medical Center (US)
  • Second Affiliated Hospital of Xi'an Jiaotong University (CN)
  • Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Corresponding author
  • Yeo, Yee Hui
  • Rezaie, Ali
Venue
Annals of Internal Medicine
Published
2024-09
Volume
177
Issue
9
Pages
1289-1291
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W4400874445
Cited by
90
References
3
Citations by year
2026: 41 · 2025: 38 · 2024: 11
FWCI
29.64
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
GLP-1 receptor agonists, prescribing trends, medication use, type 2 diabetes, anti-obesity drugs, prescribing patterns
MeSH terms
Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Practice Patterns, Physicians', Drug Prescriptions, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Shifting Trends in the Indication of Glucagon-like Peptide-1 Receptor Agonist Prescriptions: A Nationwide Analysis. https://app.cochat.ai/papers/10.7326/m24-0019
The paper
Yeo, Y. H., Rezaie, A., Hsieh, T. Y.-J., Hu, X., Gaddam, S., Ma, K. S.-K., Gastrointestinal Motility and Metabolic Pharmacoepidemiology Group, Mohamed, G., Lee, G. Y., Huang, P.-C., Watson, R., Mohamed, G., Lee, G. Y., Huang, P.-C., & Watson, R. (2024). Shifting Trends in the Indication of Glucagon-like Peptide-1 Receptor Agonist Prescriptions: A Nationwide Analysis. Annals of Internal Medicine. https://doi.org/10.7326/m24-0019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.